Methamphetamine: Effects, Treatment, and Legal Status
This paper examines methamphetamine (meth) as a designer drug, exploring its chemical composition, street names, and mechanism of action in the brain. It details the euphoric and adverse effects users experience, including withdrawal symptoms and long-term behavioral and physical health consequences. The paper also discusses evidence-based treatment approaches such as cognitive behavioral therapy, overdose management protocols, and meth's current legal classification under the United States Controlled Substances Act as a Schedule II stimulant. The limited medical use of the legally approved formulation, Desoxyn, is also addressed.
- Introduction to Methamphetamine: Chemical makeup, street names, and brain mechanism
- Short-Term Effects and Withdrawal: Euphoria, crash cycle, and withdrawal symptoms
- Behavioral and Physical Health Consequences: Long-term cognitive, physical, and behavioral damage
- Treatment Approaches: CBT, overdose management, and recovery strategies
- Legal Status and Medical Use: Schedule II classification and Desoxyn approval
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper integrates peer-reviewed sources consistently, grounding pharmacological claims about dopamine release, cardiovascular effects, and cognitive decline in cited research.
- It moves logically from chemical composition and immediate effects through long-term consequences to treatment and legal status, creating a coherent informational arc.
- Specific clinical details — such as the mechanism of intestinal ischemia and the use of activated charcoal for oral overdose — demonstrate engagement with the primary literature beyond surface-level description.
Key academic technique demonstrated
The paper effectively uses direct quotation with page-number citations to support technical pharmacological claims, reserving paraphrase for more general contextual points. This disciplined use of evidence strengthens credibility when describing complex neurological and physiological effects that require precise attribution.
Structure breakdown
The paper opens with an introduction to meth's chemical makeup and mechanism of action, then covers short-term effects and withdrawal, followed by a detailed discussion of behavioral and physical health consequences. It then turns to treatment — cognitive behavioral therapy and overdose management — before concluding with meth's legal standing and its narrow approved medical application. Each section builds naturally on the previous one, moving from cause to consequence to intervention to policy.
Introduction to Methamphetamine
Methamphetamine (meth) is a designer drug known by numerous street names, including speed, crank, ice, chalk, dunk, Batu, Tina, Go-Fast, Shabu, Tweak, Glass, Crystal, and Scooby Snax (DEA, 2020). Meth belongs to the group of drugs known as stimulants. It increases the amount of dopamine naturally produced in the brain, giving the user an intense high. As Prakash et al. (2017) point out, "the euphoric effects of METH occur due to release of the neurotransmitter dopamine, which is involved in the experience of pleasure, motivation and motor function" (p. 3). Because this high is so powerful, users quickly want to experience it again and again.
Meth can be sold as a powder, rock, base, or pill. The drug is made using the primary ingredients of ephedrine and pseudoephedrine, which can be obtained from over-the-counter cold medications. These ingredients are combined with other substances that can be sourced from common household items, such as lithium (from car batteries), acetone (paint thinner), Freon (air conditioning units), gasoline, and sulfuric acid (from cleaners). The drug is most commonly consumed by smoking it and inhaling the vapors.
Short-Term Effects and Withdrawal
An individual using meth experiences a range of euphoric sensations. The user becomes more talkative and experiences increased alertness, energy, and heightened sexual arousal. Increased hostility or aggression and feelings of superiority over others may also occur. However, following the intense high is a crash that plunges the person in the opposite direction: depression, anxiety, and a powerful craving for the drug all set in.
Without a return to meth, the user experiences withdrawal symptoms, which include fatigue, dry mouth, increased appetite, jittery nerves, lethargy, sleepiness, apathy, despair, and even paranoia, hallucinations, and delusions (Liang, Wang & Yuan, 2018).
Behavioral and Physical Health Consequences
Behavioral and mental health effects of meth use include insomnia, reduced concentration, memory loss, psychotic behavior, suicidal ideation, violence, and paranoia. Psychotic effects include hallucinations and the belief that someone is pursuing the user, or hearing things that are not there. These effects occur because the brain is overly stimulated by the drug. Physical health effects can be seen in skin changes and tooth decay, as well as in the central nervous system, immune system, and gastrointestinal system (Prakash et al., 2017).
For instance, meth "induces peripheral kidney and liver damage that leads to toxic ammonia levels in the blood and subsequently, the brain" (Prakash et al., 2017, p. 3). Additionally, "the rapid and sustained release of norepinephrine following meth use results in arterial vasoconstriction, leading to tachycardia and hypertension. Similar effects can also be seen in the mesenteric vessels of the gut, leading to acute intestinal ischemia" (Prakash et al., 2017, p. 5).
Long-term behavioral effects linked to meth use include social isolation, mood disturbances, violence, paranoia, hallucinations, delusions, and psychotic tendencies. Prakash et al. (2017) note that "long-term use of METH causes molecular changes in the dopamine system, contributing to nerve terminal damage in the brain and leading to impaired motor skills, rapid cognitive decline, increased anxiety, psychotic disorders, violent behaviour, hallucination, delusions and depression" (p. 3).
References
DEA. (2020). Drug fact sheet. Retrieved from https://www.dea.gov/sites/default/files/2020-06/Methamphetamine-2020_0.pdf
Liang, Y., Wang, L., & Yuan, T. F. (2018). Targeting withdrawal symptoms in men addicted to methamphetamine with transcranial magnetic stimulation: A randomized clinical trial. JAMA Psychiatry, 75(11), 1199–1201.
Prakash, M. D., Tangalakis, K., Antonipillai, J., Stojanovska, L., Nurgali, K., & Apostolopoulos, V. (2017). Methamphetamine: Effects on the brain, gut and immune system. Pharmacological Research, 120, 60–67.
Shakiba, K., Effatpanah, M., & Moradi, A. (2018). Cognitive-behavioral therapy for methamphetamine dependence among methadone-maintained patients. Iranian Journal of Psychiatry and Behavioral Sciences, 12(2).
Create your account
Always verify citation format against your institution’s current style guide requirements.